Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Length of urinary catheter use after colorectal (pelvic) surgery

Official title: Optimal Duration of Urinary Catheterization After Total Mesorectal Excision

Run by University of Southern California · NCT04359069 · Data updated 2026-11-12

This trial tests whether removing the urinary catheter on postoperative day 1 instead of day 3 is safe for adults having total mesorectal excision for rectal disease.

More Colorectal Surgery trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment176 (estimated)
SponsorUniversity of Southern California
Academic / other
Drugs / interventionschemotherapy, radiation
Locations2 sites (Los Angeles, California and 1 other locations)
StatusRecruiting
StartedOctober 1, 2020
Main results expectedJanuary 2028
Study endsJanuary 2029
Registry record updatedFebruary 5, 2026
Trial IDNCT04359069 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) undergoing elective total mesorectal excision (low anterior resection, abdominoperineal resection, or proctectomy for IBD) of ASA class I–III, including those who had neoadjuvant therapy, are ideal candidates.

Probably not a fit

Patients having urgent/emergent surgery, combined major procedures, intraoperative genitourinary injury, or a history of postoperative urinary retention are excluded and unlikely to benefit from the protocol tested.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized, non-inferiority trial comparing urinary catheter removal on postoperative day 1 versus day 3 after elective total mesorectal excision (including low anterior resection, abdominoperineal resection, and proctectomy for IBD). Adult patients (≥18 years, ASA I-III) undergoing open, laparoscopic, or robotic approaches are randomized to early or standard catheter removal and monitored for postoperative urinary retention, urinary tract infections, and length of hospital stay. The trial excludes emergent surgeries, concurrent major procedures, genitourinary injuries, and patients with prior urinary retention, and follows patients through the immediate postoperative period to capture catheter-related outcomes. The goal is to determine if a shorter catheter duration avoids additional retention while reducing catheter-associated complications.

Why it matters

Potential benefit: If successful, earlier catheter removal could lower urinary tract infections and shorten hospital stays without increasing urinary retention.

How similar studies have gone: Prior research has been mixed: an older randomized trial showed higher retention with early removal, but recent retrospective data and a newer randomized non-inferiority trial using oral alpha-antagonists found early removal non-inferior with fewer UTIs and shorter stays.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Elective procedures involving total mesorectal excision, including low anterior resection and abdominoperineal resection for rectal cancer as well as proctectomy for inflammatory bowel disease.
* All approaches (open, laparoscopic and robotic) will be included, as the approaches not differ in the total mesorectal excision technique.
* Patients who received neoadjuvant chemotherapy and/or radiation treatments will be included.
* Age ≥ 18 years.
* American Society of Anesthesiologists (ASA) class I-III.
* Ability to understand and the willingness to sign a written informed consent.

Exclusion Criteria:

* Patients undergoing emergent or urgent surgery.
* Patients undergoing total mesorectal excision in combination with other major surgical procedures on the same day should be excluded from this study.
* Patients sustaining genitourinary tract injury during the procedure should be excluded postoperatively.
* History of urinary retention after previous procedure, surgery, or urinary catheter removal.
* History of urinary retention not being actively treated.
* Patients requiring prolonged duration or replacement of urinary catheter in the postoperative period for reasons other than urinary retention should be excluded.
* History of neurogenic bladder.
* Patients with chronic indwelling Foley catheterization or suprapubic catheterization.
* History of cystectomy and/or any surgically created urinary conduit, including neobladder and ileal conduit.
* Patients less than 18 years of age should be excluded from this study.
* Vulnerable patients including incarcerated patients or any patients unable or unwilling to provide informed consent will be excluded from this study.

Where it's running

  • Keck Hospital of USC
    Los Angeles, California, United States
    Recruiting
  • Los Angeles County Hospital (LAC/USC)
    Los Angeles, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.